These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31042669)

  • 21. Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-controlled trial.
    Fleischmann RM; Schechtman J; Bennett R; Handel ML; Burmester GR; Tesser J; Modafferi D; Poulakos J; Sun G
    Arthritis Rheum; 2003 Apr; 48(4):927-34. PubMed ID: 12687534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison between the 1-microg adrenocorticotropin (ACTH) test, the short ACTH (250 microg) test, and the insulin tolerance test in the assessment of hypothalamo-pituitary-adrenal axis immediately after pituitary surgery.
    Dökmetaş HS; Colak R; Keleştimur F; Selçuklu A; Unlühizarci K; Bayram F
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3713-9. PubMed ID: 11061529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of naproxen on the hypothalamic-pituitary-adrenal axis in healthy volunteers.
    Eijsbouts AM; Kempers MJ; Kramer RS; Hopman MT; van den Hoogen FH; Laan RF; Hermus AR; Sweep FC; van de Putte LB
    Br J Clin Pharmacol; 2009 Jan; 67(1):22-8. PubMed ID: 19133058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in corticotropin-releasing hormone-stimulated adrenocorticotropin and cortisol before and after weight loss.
    Yanovski JA; Yanovski SZ; Gold PW; Chrousos GP
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1874-8. PubMed ID: 9177399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of adrenocorticotropin (ACTH) stimulation tests and insulin hypoglycemia in normal humans: low dose, standard high dose, and 8-hour ACTH-(1-24) infusion tests.
    Nye EJ; Grice JE; Hockings GI; Strakosch CR; Crosbie GV; Walters MM; Jackson RV
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3648-55. PubMed ID: 10523009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison between low-dose (1 microg), standard-dose (250 microg) ACTH stimulation tests and insulin tolerance test in the evaluation of hypothalamo-pituitary-adrenal axis in primary fibromyalgia syndrome.
    Kirnap M; Colak R; Eser C; Ozsoy O; Tutus A; Kelestimur F
    Clin Endocrinol (Oxf); 2001 Oct; 55(4):455-9. PubMed ID: 11678827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Glucagon-Like Peptide-1 Receptor Agonists on Hypothalamic-Pituitary-Adrenal Axis in Healthy Volunteers.
    Winzeler B; da Conceição I; Refardt J; Sailer CO; Dutilh G; Christ-Crain M
    J Clin Endocrinol Metab; 2019 Jan; 104(1):202-208. PubMed ID: 30272170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced circadian ACTH release in obese premenopausal women: reversal by short-term acipimox treatment.
    Kok P; Kok SW; Buijs MM; Westenberg JJ; Roelfsema F; Frölich M; Stokkel MP; Meinders AE; Pijl H
    Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E848-56. PubMed ID: 15280154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anakinra: efficacy in the management of fever during neutropenia and mucositis in autologous stem cell transplantation (AFFECT-2)-study protocol for a multicenter randomized double-blind placebo-controlled trial.
    de Mooij CEM; van Groningen LFJ; de Haan AFJ; Biemond BJ; Bakker M; van der Velden WJFM; Blijlevens NMA
    Trials; 2020 Nov; 21(1):948. PubMed ID: 33225965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment with Anakinra improves disposition index but not insulin sensitivity in nondiabetic subjects with the metabolic syndrome: a randomized, double-blind, placebo-controlled study.
    van Asseldonk EJ; Stienstra R; Koenen TB; Joosten LA; Netea MG; Tack CJ
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2119-26. PubMed ID: 21508140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of desipramine on basal and naloxone-stimulated cortisol secretion in humans: interaction of two drugs acting on noradrenergic control of adrenocorticotropin secretion.
    Torpy DJ; Grice JE; Hockings GI; Crosbie GV; Walters MM; Jackson RV
    J Clin Endocrinol Metab; 1995 Mar; 80(3):802-6. PubMed ID: 7883833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.
    Bertagna X; Escourolle H; Pinquier JL; Coste J; Raux-Demay MC; Perles P; Silvestre L; Luton JP; Strauch G
    J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of anakinra monotherapy on joint damage in patients with rheumatoid arthritis. Extension of a 24-week randomized, placebo-controlled trial.
    Bresnihan B; Newmark R; Robbins S; Genant HK
    J Rheumatol; 2004 Jun; 31(6):1103-11. PubMed ID: 15170922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concomitant medication use in a large, international, multicenter, placebo controlled trial of anakinra, a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis.
    Tesser J; Fleischmann R; Dore R; Bennett R; Solinger A; Joh T; Modafferi D; Schechtman J;
    J Rheumatol; 2004 Apr; 31(4):649-54. PubMed ID: 15088288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of IL-1 in the regulation of copeptin in patients with metabolic syndrome.
    Popovic M; Ebrahimi F; Urwyler SA; Donath MY; Christ-Crain M
    Endocr Connect; 2020 Jul; 9(7):715-723. PubMed ID: 32698151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anakinra for Colchicine-Resistant Familial Mediterranean Fever: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Ben-Zvi I; Kukuy O; Giat E; Pras E; Feld O; Kivity S; Perski O; Bornstein G; Grossman C; Harari G; Lidar M; Livneh A
    Arthritis Rheumatol; 2017 Apr; 69(4):854-862. PubMed ID: 27860460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-1 inhibition and fatigue in primary Sjögren's syndrome--a double blind, randomised clinical trial.
    Norheim KB; Harboe E; Gøransson LG; Omdal R
    PLoS One; 2012; 7(1):e30123. PubMed ID: 22253903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial.
    Cohen S; Hurd E; Cush J; Schiff M; Weinblatt ME; Moreland LW; Kremer J; Bear MB; Rich WJ; McCabe D
    Arthritis Rheum; 2002 Mar; 46(3):614-24. PubMed ID: 11920396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Influence of interleukin-1 and interleukin-6 on modulation of hypothalamo-pituitary-adrenal axis in pregnancy at term and in spontaneous and oxytocin-induced delivery].
    Ochedalski T; Lachowicz A
    Ginekol Pol; 2003 Oct; 74(10):1228-35. PubMed ID: 14669422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-1 Blockade in Acute Decompensated Heart Failure: A Randomized, Double-Blinded, Placebo-Controlled Pilot Study.
    Van Tassell BW; Abouzaki NA; Oddi Erdle C; Carbone S; Trankle CR; Melchior RD; Turlington JS; Thurber CJ; Christopher S; Dixon DL; Fronk DT; Thomas CS; Rose SW; Buckley LF; Dinarello CA; Biondi-Zoccai G; Abbate A
    J Cardiovasc Pharmacol; 2016 Jun; 67(6):544-51. PubMed ID: 26906034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.